CTI BioPharma Corp. appointed Michael Metzger as a board member.
Metzger is currently president and COO of Syndax Pharmaceuticals Inc.
Discover more about S&P Global’s offerings
CTI BioPharma adds Syndax COO to board
Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills
Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds
Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall
Global M&A By the Numbers: Q1 2022
CTI BioPharma Corp. appointed Michael Metzger as a board member.
Metzger is currently president and COO of Syndax Pharmaceuticals Inc.